Comparative Efficacy and Tolerability of Front-Line Treatments for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: An Update Network Meta-Analysis

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-6039-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Relative Efficacy of Treatments in First-Line Management of Newly Diagnosed Chronic Myeloid Leukaemia: Systematic Literature Review and Indirect Comparison

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Comparative Efficacy of Pharmacological and Nonpharmacological Treatments for Chronic Idiopathic Constipation in China: A Bayesian Network Meta-Analysis

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2019English

Tolerability of Opioid Analgesia for Chronic Pain: A Network Meta-Analysis

Scientific Reports
Multidisciplinary
2017English

Long-Term Follow-Up of Lower Dose Dasatinib (50 Mg Daily) as Frontline Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Cancer
Cancer ResearchOncology
2019English

Nilotinib vs Imatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase: ENESTnd 3-Year Follow-Up

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Update of Recent Studies in Chronic Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2009English

Matching Adjusted Indirect Comparison (MAIC) Analysis for Ponatinib vs Bosutinib in Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Chromosomal Abnormalities in Philadelphia Chromosome Negative Metaphases Appearing During Imatinib Mesylate Therapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Blood
BiochemistryImmunologyCell BiologyHematology
2007English

Impact of Malignant Stem Cell Burden on Therapy Outcome in Newly Diagnosed Chronic Myeloid Leukemia Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy